These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 26685315
1. Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation. Fontenot AP, Falta MT, Kappler JW, Dai S, McKee AS. J Immunol; 2016 Jan 01; 196(1):22-7. PubMed ID: 26685315 [Abstract] [Full Text] [Related]
2. Metal-specific CD4+ T-cell responses induced by beryllium exposure in HLA-DP2 transgenic mice. Falta MT, Tinega AN, Mack DG, Bowerman NA, Crawford F, Kappler JW, Pinilla C, Fontenot AP. Mucosal Immunol; 2016 Jan 01; 9(1):218-28. PubMed ID: 26129650 [Abstract] [Full Text] [Related]
3. Immunologic Effects of Beryllium Exposure. Fontenot AP. Ann Am Thorac Soc; 2018 Apr 01; 15(Suppl 2):S81-S85. PubMed ID: 29676647 [Abstract] [Full Text] [Related]
4. Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease. Mack DG, Falta MT, McKee AS, Martin AK, Simonian PL, Crawford F, Gordon T, Mercer RR, Hoover MD, Marrack P, Kappler JW, Tuder RM, Fontenot AP. Proc Natl Acad Sci U S A; 2014 Jun 10; 111(23):8553-8. PubMed ID: 24912188 [Abstract] [Full Text] [Related]
6. Identification of multiple public TCR repertoires in chronic beryllium disease. Bowerman NA, Falta MT, Mack DG, Wehrmann F, Crawford F, Mroz MM, Maier LA, Kappler JW, Fontenot AP. J Immunol; 2014 May 15; 192(10):4571-80. PubMed ID: 24719461 [Abstract] [Full Text] [Related]
7. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP. J Immunol; 2005 Nov 15; 175(10):7029-37. PubMed ID: 16272364 [Abstract] [Full Text] [Related]
8. Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. Falta MT, Pinilla C, Mack DG, Tinega AN, Crawford F, Giulianotti M, Santos R, Clayton GM, Wang Y, Zhang X, Maier LA, Marrack P, Kappler JW, Fontenot AP. J Exp Med; 2013 Jul 01; 210(7):1403-18. PubMed ID: 23797096 [Abstract] [Full Text] [Related]
9. T cell recognition of beryllium. Dai S, Falta MT, Bowerman NA, McKee AS, Fontenot AP. Curr Opin Immunol; 2013 Dec 01; 25(6):775-80. PubMed ID: 23978481 [Abstract] [Full Text] [Related]
10. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL. Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12717-22. PubMed ID: 11050177 [Abstract] [Full Text] [Related]
11. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. Fontenot AP, Maier LA. Trends Immunol; 2005 Oct 07; 26(10):543-9. PubMed ID: 16099719 [Abstract] [Full Text] [Related]
12. Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity. Clayton GM, Wang Y, Crawford F, Novikov A, Wimberly BT, Kieft JS, Falta MT, Bowerman NA, Marrack P, Fontenot AP, Dai S, Kappler JW. Cell; 2014 Jul 03; 158(1):132-42. PubMed ID: 24995984 [Abstract] [Full Text] [Related]
13. Linking genetic susceptibility and T cell activation in beryllium-induced disease. Falta MT, Bowerman NA, Dai S, Kappler JW, Fontenot AP. Proc Am Thorac Soc; 2010 May 03; 7(2):126-9. PubMed ID: 20427584 [Abstract] [Full Text] [Related]
14. Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation. Falta MT, Crawford JC, Tinega AN, Landry LG, Crawford F, Mack DG, Martin AK, Atif SM, Li L, Santos RG, Nakayama M, Kappler JW, Maier LA, Thomas PG, Pinilla C, Fontenot AP. J Clin Invest; 2021 May 03; 131(9):. PubMed ID: 33630763 [Abstract] [Full Text] [Related]
15. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R. J Immunol; 2001 Mar 01; 166(5):3549-55. PubMed ID: 11207315 [Abstract] [Full Text] [Related]
16. T cell recognition in chronic beryllium disease. Amicosante M, Fontenot AP. Clin Immunol; 2006 Nov 01; 121(2):134-43. PubMed ID: 16697706 [Abstract] [Full Text] [Related]
17. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. Amicosante M, Sanarico N, Berretta F, Arroyo J, Lombardi G, Lechler R, Colizzi V, Saltini C. Hum Immunol; 2001 Jul 01; 62(7):686-93. PubMed ID: 11423174 [Abstract] [Full Text] [Related]
18. Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, Marrack P, Kappler JW, Fontenot AP. Proc Natl Acad Sci U S A; 2010 Apr 20; 107(16):7425-30. PubMed ID: 20356827 [Abstract] [Full Text] [Related]
19. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. Fontenot AP, Newman LS, Kotzin BL. Clin Immunol; 2001 Jul 20; 100(1):4-14. PubMed ID: 11414740 [No Abstract] [Full Text] [Related]
20. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity. Rogliani P, Amicosante M, Berretta F, Dotti C, Bocchino M, O'Donnell KM, Saltini C. Int J Immunopathol Pharmacol; 2004 Jul 20; 17(2 Suppl):3-10. PubMed ID: 15345185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]